ACCENDRA HEALTH INC/VA/·4

Mar 10, 9:01 PM ET

Galloway Heath H 4

4 · ACCENDRA HEALTH INC/VA/ · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

ACCENDRA HEALTH (ACH) EVP Heath H. Galloway Receives 61,437-Share Award

What Happened Heath H. Galloway, EVP, General Counsel & Corporate Secretary of Accendra Health Inc. (ACH), was granted 61,437 restricted shares on 2026-03-09. The Form 4 reports an acquisition (award) at $0.00 — the filing lists no cash purchase price or immediate proceeds.

Key Details

  • Transaction date: 2026-03-09; Form 4 filed: 2026-03-10 (timely).
  • Transaction type/code: Award/Grant (A); reported acquisition price: $0.00.
  • Shares granted: 61,437 restricted common shares.
  • Shares owned after the transaction: not specified in the filing.
  • Footnote: the restricted stock vests one‑third per year over three years.
  • Filing accession: 0000075252-26-000006.

Context This was a compensation award (restricted stock), not an open‑market purchase or sale. Because the shares vest over time, they are subject to forfeiture/vesting conditions and do not represent an immediate sale or cash inflow. Awards like this are routine executive compensation and should be interpreted as such rather than a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-03-09
Galloway Heath H
EVP,General Counsel & CorpSecy
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-09+61,437178,441 total
Footnotes (1)
  • [F1]Restricted stock grant which vests one-third per year over three years.
Signature
Heath H. Galloway by Rosemarie France, POA|2026-03-10

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES